UBV
CRDF icon

United Bank (Virginia)’s Cardiff Oncology CRDF Stock Holding History

United Bank (Virginia)’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,411
Closed -$36.3K – 131
2026
Q1 		$36.3K Hold
22,411
– – ﹤0.01% 120
2025
Q4 		$63K Hold
22,411
– – 0.01% 127
2025
Q3 		$46.2K Hold
22,411
– – 0.01% 127
2025
Q2 		$70.6K Sell
22,411
-500
-2% -$1.52K 0.01% 137
2025
Q1 		$71.9K Hold
22,911
– – 0.01% 134
2024
Q4 		$99.4K Buy
22,911
+4,911
+27% +$15.3K 0.01% 130
2024
Q3 		$48.1K Hold
18,000
– – 0.01% 136
2024
Q2 		$40K Buy
18,000
+2,500
+16% +$9.42K 0.01% 138
2024
Q1 		$82.8K Buy
15,500
+2,500
+19% +$6.64K 0.01% 141
2023
Q4 		$19.2K Buy
+13,000
New +$15.7K ﹤0.01% 145

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

United Bank (Virginia)'s CRDF Position: Q2 2026 in Review

United Bank (Virginia) sold out of Cardiff Oncology (CRDF) in Q2 2026, closing a stake of 22,411 shares — an estimated $36.3K sold.

United Bank (Virginia) first reported a position in CRDF in Q4 2023 and held it in 10 quarters. The position peaked at $99.4K in Q4 2024. 104 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • United Bank (Virginia) reported no remaining Cardiff Oncology position as of Q2 2026 after selling out during the quarter.
  • United Bank (Virginia) sold 22,411 Cardiff Oncology shares in Q2 2026, an estimated $36.3K.
  • United Bank (Virginia) first reported a position in Cardiff Oncology in Q4 2023 and held it in 10 quarters.
  • United Bank (Virginia)'s Cardiff Oncology position peaked at $99.4K in Q4 2024.
  • 104 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on United Bank (Virginia)'s 13F filing for Q2 2026, filed 30 Jul 2026.